Overview

Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy

Status:
Completed

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

A phase II study of combination therapy of carboplatin -gemcitabine plus bevacizumab beyond progression in patients with locally advanced and/or metastatic non-small cell lung cancer (NSCLC) who have not received prior chemotherapy.

Phase:

Phase 2

Details

Lead Sponsor:

Radboud University

Treatments:

Bevacizumab
Carboplatin
Erlotinib Hydrochloride
Gemcitabine
Paclitaxel